This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk A/s. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: The Innovations of Anders R Sorensen
Introduction
Anders R Sorensen is a notable inventor based in Herlev, Denmark. He has made significant contributions to the field of pharmacology, particularly in the area of drug delivery systems. His innovative approach has led to advancements that enhance the effectiveness of certain medications.
Latest Patents
Anders holds a patent for a nasal formulation and intranasal administration method. This patent focuses on enhancing systemic absorption after intranasal administration of specific drugs, especially pharmacologically active polypeptides. The presence of a phospholipid, such as phosphatidylcholine (a lecithin), combined with a vegetable oil, plays a crucial role in this enhancement.
Career Highlights
Anders R Sorensen is associated with Novo Nordisk A/S, a leading global healthcare company. His work at Novo Nordisk has allowed him to explore innovative solutions in drug delivery, contributing to the company's mission of improving patient care.
Collaborations
Anders collaborates with Philip E Hansen, a fellow professional in the field. Their partnership exemplifies the importance of teamwork in driving innovation and achieving breakthroughs in pharmaceutical research.
Conclusion
Anders R Sorensen's contributions to the field of pharmacology through his patent and work at Novo Nordisk highlight the impact of innovative thinking in healthcare. His advancements in drug delivery systems are paving the way for more effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile